CCDC137 affects sorafenib resistance in hepatocellular carcinoma cells by activating the AKT/mTOR signaling pathway

Clinical & Translational Oncology 2026

View at publisher

Authors: Hanchuan Tao, Yu Fei Wang, fang Wang, Xingchi Hu, Cheng Wang

DOI: 10.1007/s12094-026-04244-5

Cited by: 1

References: 33

Fields of Study & Subjects

PI3K/AKT/mTOR signaling in cancer Cancer-related Molecular Pathways Hepatocellular Carcinoma Treatment and Prognosis

References 33